An observational study in Hyperandrogenism, Obesity and Metabolic Disease, sponsored by Medical University of Gdansk. Status unknown at 1 site in Poland. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2021-11-08.
Sponsored by Medical University of Gdansk · Observational
Assessement of basic metabolic profile and adipokine levels in young hyperandrogenemic females.
81 studies on the registry are indexed under Hyperandrogenism; 22 are open to participants now.
This study's planned enrollment of 40 is below the median of 135 across 26 observational studies indexed under Hyperandrogenism.
Browse Hyperandrogenism studies →Medical University of Gdansk is the lead sponsor of 133 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Hyperandrogenemic females admitted for additional assessment due to medical reasons.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Basic metabolic profile.
Serum lipids, uric acid, fasting glucose and insulin.
Time frame: Day of blood testing - no further assessment planned (observational study).
Adipokines.
Time frame: Day of blood testing - no further assessment planned (observational study).
Started Sep 2021 (actual). Primary completion is estimated for Jun 2022, 9 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Gdansk →